The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Open accessAbstract
Pathological gambling (PG) related to dopaminergic treatment in Parkinson's disease (PD) is part of a spectrum of behavioral disorders called the dopamine dysregulation syndrome (DDS). We describe a series of PD patients with preoperative active PG due to dopaminergic treatment from a total of 598 patients who have undergone surgery for subthalamic nucleus stimulation for disabling motor fluctuations. The patients had systematic open assessment of behavioral symptoms and standardized assessments of motor symptoms, mood, and apathy. Seven patients (6 men, 1 woman; age, 54 ± 9 years; levodopa equivalent dose, 1,390 ± 350 mg/day) had preoperative PG over a mean of 7 years, intolerant to reduction in medication. Six had nonmotor fluctuations and four had other behavioral symptoms consistent with a diagnosis of the DDS. After surgery, motor symptoms improved, allowing for 74% reduction of dopaminergic treatment, below the dosage of gambling onset. In all patients, PG resolved postoperatively after 18 months on average (range, 0–48), although transient worsening occurred in two. Improvement paralleled the time course and degree of reduction in dopaminergic treatment. Nonmotor fluctuations, off period dysphoria, and other symptoms of the DDS improved. Two patients developed persistent apathy. In conclusion, PG and other symptoms of the DDS‐associated dopaminergic treatment improved in our patients following surgery. Dopaminergic dysregulation commonly attributed to pulsatile overstimulation of the limbic dopaminergic system may be subject to desensitization on chronic subthalamic stimulation, which has a relative motor selectivity and allows for decrease in dopaminergic treatment. © 2006 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
Self-citationDiscrete coding of reward probability and uncertainty by dopamine neurons
Fiorillo, C. D., Tobler, P. N., & Schultz, W. (2003) · Science · doi:10.1126/science.1077349 · Cited by 2,085
Bechara, A., Tranel, D., & Damasio, H. (2000) · Brain · doi:10.1093/brain/123.11.2189 · Cited by 1,919
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Reliability, validity, and clinical correlates of apathy in Parkinson's disease
(1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.2.134 · Cited by 1,185
Pathological gambling is linked to reduced activation of the mesolimbic reward system
Reuter, J., Raedler, T., Rose, M., Hand, I., Gläscher, J., & Büchel, C. (2005) · Nature Neuroscience · doi:10.1038/nn1378 · Cited by 734
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., Asser, T., & Aquilonius, S.-M. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00818.x · Cited by 665
Giovannoni, G. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587
Range of neuropsychiatric disturbances in patients with Parkinson's disease
Aarsland, D., Larsen, J. P., Lim, N. G., Janvin, C., Karlsen, K., Tandberg, E., & Cummings, J. L. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.492 · Cited by 581
Funkiewiez, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.009803 · Cited by 572
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563
Cools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(03)00117-9 · Cited by 516
Behavioural disorders, Parkinson's disease and subthalamic stimulation
Houeto, J. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.701 · Cited by 500
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up
Schupbach, W. M. M. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063206 · Cited by 425
Frontal lobe dysfunction in pathological gambling patients
Cavedini, P., Riboldi, G., Keller, R., D’Annucci, A., & Bellodi, L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01227-6 · Cited by 418
Gambling Urges in Pathological Gambling: A Functional Magnetic Resonance Imaging Study
Potenza, M. N., Steinberg, M. A., Skudlarski, P., Fulbright, R. K., Lacadie, C. M., Wilber, M. K., Rounsaville, B. J., Gore, J. C., & Wexler, B. E. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.828 · Cited by 414
Kleiner-Fisman, G., Fisman, D. N., Sime, E., Saint-Cyr, J. A., Lozano, A. M., & Lang, A. E. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0489 · Cited by 351
Self-citationPathological gambling associated with dopamine agonist therapy in Parkinson’s disease
Driver-Dunckley, E., Samanta, J., & Stacy, M. (2003) · Neurology · doi:10.1212/01.wnl.0000076478.45005.ec · Cited by 313
Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour
Brown, R. G., & Pluck, G. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01626-x · Cited by 303
Katzenschlager, R., Hughes, A., Evans, A., Manson, A. J., Hoffman, M., Swinn, L., Watt, H., Bhatia, K., Quinn, N., & Lees, A. J. (2005) · Movement Disorders · doi:10.1002/mds.20276 · Cited by 286
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
Lawrence, A. D., Evans, A. H., & Lees, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00529-5 · Cited by 282
Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., Moro, E., Benabid, A., & Pollak, P. (2003) · Movement Disorders · doi:10.1002/mds.10441 · Cited by 264
Self-citationCompulsive eating and weight gain related to dopamine agonist use
Nirenberg, M. J., & Waters, C. (2006) · Movement Disorders · doi:10.1002/mds.20757 · Cited by 262
Dopamine dysregulation syndrome in Parkinson's disease
Evans, A. H., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137528.23126.41 · Cited by 257
Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment?
Molina, J. A., S�inz-Artiga, M. J., Fraile, A., Jim�nez-Jim�nez, F. J., Villanueva, C., Ort�-Pareja, M., & Bermejo-P, F. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<869::aid-mds1016>3.0.co;2-i · Cited by 253
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
Witjas, T., Baunez, C., Henry, J. M., Delfini, M., Regis, J., Cherif, A. A., Peragut, J. C., & Azulay, J. P. (2005) · Movement Disorders · doi:10.1002/mds.20501 · Cited by 238
Krack, P. (1999) · Brain · doi:10.1093/brain/122.6.1133 · Cited by 229
Self-citationDoes subthalamic nucleus stimulation induce apathy in Parkinson’s disease?
Drapier, D., Drapier, S., Sauleau, P., Haegelen, C., Raoul, S., Biseul, I., Peron, J., Lallement, F., Rivier, I., Reymann, J. M., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0177-0 · Cited by 221
Neurobiology of decision-making: Risk and reward
Bechara, A. (2001) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2001.22927 · Cited by 191
The Mattis Dementia Rating Scale: Normative data from 1,001 healthy volunteers
Schmidt, R., Freidl, W., Fazekas, F., Reinhart, B., Grieshofer, P., Koch, M., Eber, B., Schumacher, M., Polmin, K., & Lechner, H. (1994) · Neurology · doi:10.1212/wnl.44.5.964 · Cited by 186
Krack, P., Limousin, P., Benabid, A., & Pollak, P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64273-0 · Cited by 165
Self-citationEnhanced Food-Related Motivation after Bilateral Lesions of the Subthalamic Nucleus
Baunez, C., Amalric, M., & Robbins, T. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00562.2002 · Cited by 163
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
Nutt, J. G., Obeso, J. A., & Stocchi, F. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00029-x · Cited by 157
Potenza, M. N. (2001) · JAMA · doi:10.1001/jama.286.2.141 · Cited by 144
Deep Brain Stimulation of the Subthalamic Nucleus Enhances Emotional Processing in Parkinson Disease
Schneider, F. W., Habel, U., Volkmann, J., Regel, S. J., Kornischka, J., Sturm, V., & Freund, H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.296 · Cited by 142
Levodopa and the progression of Parkinson’s disease
Morgan, J. C., & Sethi, K. D. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0069-1 · Cited by 123
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
Czernecki, V. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033258 · Cited by 118
Self-citationReward-related neuronal activity in the subthalamic nucleus of the monkey
Darbaky, Y., Baunez, C., Arecchi, P., Legallet, E., & Apicella, P. (2005) · Neuroreport · doi:10.1097/00001756-200508010-00022 · Cited by 95
Levodopa‐induced dyskinesias in Parkinson's disease: Is sensitization reversible?
Bejjani, B.-P. W., Arnulf, I., Demeret, S., Damier, P., Bonnet, A., Houéto, J., & Agid, Y. (2000) · Annals of Neurology · Cited by 82
Self-citationMuriel, M., Agid, Y., & Hirsch, É. C. (2001) · Movement Disorders · doi:10.1002/mds.1103 · Cited by 16
Self-citation
Cited by
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder
Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M.-L., Fontaine, D., Montcel, S. T. D., Yelnik, J., Chéreau, I., Arbus, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708514 · Cited by 965
Self-citationThe scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Thobois, S., Ardouin, C., Lhommee, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Coelho Braga, M. C., Hassani, R., Kistner, A., et al. (2010) · Brain · doi:10.1093/brain/awq032 · Cited by 516
Self-citationA multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D’Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., et al. (2008) · Brain · doi:10.1093/brain/awn214 · Cited by 472
Self-citationMallet, L., Schüpbach, M., N'Diaye, K., Remy, P., Bardinet, E., Czernecki, V., Welter, M.-L., Pelissolo, A., Ruberg, M., Agid, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610849104 · Cited by 437
Self-citation
Metadata
- Authors
- Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pelissolo, A., Moro, E., Lhommée, E., Lang, A. E., Agid, Y., Benabid, A., Pollak, P., Mallet, L., & Krack, P.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2006-09-13
- Volume
- 21
- Issue
- 11
- Pages
- 1941-1946
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2013572056
- Cited by
- 261
- References
- 46
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.